drugset / Trial / NCT00000338

Infusion Laboratory: Protocol 2 (Lisuride) - 3

NCT00000338

Phase 1 Unknown 2 enrolled National Institute on Drug Abuse (NIDA)
Open-labelTreatment

Summary

The purpose of this study is to evaluate clinical safety issues pertaining to lisuride, to cocaine, and to its interaction in a chronic, crack dependent population, and to determine how pretreatment with lisuride modifies the subjective as well as physiological effects of cocaine.

Timeline

Start
1996-03
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Lisuride Small molecule

Indications